ZUG, Switzerland and SAN JUAN, Puerto Rico and TORONTO, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Aphaia Pharma, a clinical-stage ...

KEY POINTS A 72-year-old man presented to the emergency department with a 2-week history of hypotension, postural dizziness, and muscle weakness. He had a medical history of HIV, lipodystrophy, ...

The students are involved in the fourth year of a partnership with Dr. Nick Burton’s Nutritional Programming and Metabolic ...

Target RWE, a leading real-world evidence solutions company, today announced the results of an innovative research study validating the new nomenclature for fatty liver disease in pediatric patients.

Struggling to drop off or missing out on a restful night's kip? A magnesium supplement might prove useful in helping you to ...

As the technology continues to improve and more quantum applications are developed we expect to see increasingly more ...

IGC Pharma, Inc. ("IGC Pharma" or the "Company") today announced additional interim data from its ongoing Phase 2 clinical trial evaluating IGC-AD1. The trial focuses on agitation in Alzheimer's as ...